Interesting that it's signed by Stern not Kim. I

Interesting that it's signed by Stern not Kim.
I think he inadvertently admitted that they only looked at evidence provided be a short seller that would obviously be biased. Never mentioned trying to contact the company or look for independent views, (like maybe the FDA,) in over a month of research.

"Second, Defendants’ contention that the initial complaint and the FAC reflect factual inaccuracies included in the short-seller report is without merit. Defendants assert that the Complaint cites the short seller report as stating that “Cellceutix is a sham company, without employees or legitimate research studies.” But no complaint contains such an allegation. Defendants assert that the complaints referred to Brilacidin as ineffective. But Plaintiffs did not rely blindly on the short seller report, but instead investigated the literature cited by the short sellers, and determined that literature to be credible. Similarly, the allegation that Kevetrin does not activate P-53 was based on a close review of the literature cited by the short seller report.